MKS Instruments looks cheap against its earnings at $260.82. The semiconductor and electronics manufacturing supplier trades at 15 times earnings, while the industry usually gets 18 times. Eighteen times next year's expected $17.65 a share implies fair value of $279.57–355.82, though that leans on forecasts sitting 167% above trailing earnings. x.com 

MKS is positioned in the hot fiber optics space and shows top IBD metrics, rising relative strength, oversold stochastics and a bullish wedge off its rising 50-day moving average. x.com 

KLA looks cheap against its earnings: at 30x next year's earnings versus the roughly 38x chip-equipment makers usually get, it sits about 9% below the low end of a $224–$285 fair range. That range is 38x next year's $6.71 EPS, give or take 12%, and leans on the forecast, which is 83% above trailing earnings; on trailing earnings it trades at 56x. This is a valuation read only, with no fundamental work. x.com 

Camtek is cheap against its earnings. At $146.79 it trades at 31x earnings, while chip-equipment makers usually get 38x. Fair value is $160.15–$203.82, or 38x next year's $4.79 a share give or take 12%, leaving the stock 8% under the low end. The read leans on the forecast, with forward earnings 154% above trailing. This is a levels-only read off reported earnings and revenue estimates, with no fundamental work. x.com 

Lam Research is cheap against its earnings, trading at 30x next year's earnings when chip-equipment makers usually get 38x. Fair value is $392.57 to $499.63, or 38x next year's $11.74 EPS give or take 12%, so at $347.49 it trades 11% below where fair starts. The valuation leans on the forecast, with forward EPS 100% above trailing. This is a levels-only read off reported earnings and revenue estimates, with no fundamental work. x.com 

SCHMID Group's risk-reward does not yet compensate for its capital structure and competitive position, though its AI recovery is real. Up to 104 million diluted shares versus 65 million outstanding, plus €154 million net debt, put it above 60x EV/EBITDA. Ten customers make up 60% of revenue; MKS Instruments leads. It gets more defensible if orders convert as guided, convertibles shrink without new issuance, a tier-one substrate maker enters qualification and no new China export curbs hit. x.com  … Show more

ASML is cheap against its earnings at 29x next year's, versus the 36x chip-equipment makers usually get. Fair value is $1,883 to $2,397, or 36x next year's $60.08 EPS give or take 12%, leaving the stock 9% below the low end. The read leans on forecasts, with forward earnings 104% above trailing, and is a valuation read only, with no fundamental work. x.com 

Amkor Technology looks expensive against its earnings, trading at 24x trailing and 19x next year's versus the roughly 18x chip-equipment makers usually get. At 18x mid-cycle EPS of $1.87, give or take 12%, fair value is $29.54-$37.60, putting the $53.86 price 43% above the top of that range. The view uses reported earnings and estimates only, without fundamental work. x.com 

Onto Innovation looks cheap against its earnings, trading at 31x forward earnings versus the roughly 38x chip-equipment makers usually get. Applying 38x to next year's forecast $9.95 a share, give or take 12%, puts fair value at about $333–423, versus $308.30 now. The case leans on that forecast, with forward EPS 102% above trailing, and rests on valuation levels from reported earnings and estimates, not fundamental work. x.com 

Microchip Technology looks cheap at 16x earnings versus the roughly 38x chipmakers usually get. Applying 38x to next year's forecast EPS of $4.57, give or take 12%, puts fair value at $152.66-194.29, and the stock at $74.17 trades 51% below the low end, with a 0.21 PEG. That leans on forward earnings 185% above trailing; above $97.02 it would be expensive. This is a valuation read only, not fundamental work. x.com